1. Home
  2. AGM vs GENB Comparison

AGM vs GENB Comparison

Compare AGM & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Agricultural Mortgage Corporation

AGM

Federal Agricultural Mortgage Corporation

HOLD

Current Price

$183.62

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.73

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AGM
GENB
Founded
1987
2018
Country
United States
United States
Employees
212
N/A
Industry
Finance Companies
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AGM
GENB
Price
$183.62
$15.73
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$215.00
$23.20
AVG Volume (30 Days)
118.8K
894.4K
Earning Date
05-05-2026
05-11-2026
Dividend Yield
3.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$25.97
N/A
Revenue Next Year
$12.21
$16.58
P/E Ratio
$9.95
N/A
Revenue Growth
N/A
N/A
52 Week Low
$136.57
$11.00
52 Week High
$210.64
$16.75

Technical Indicators

Market Signals
Indicator
AGM
GENB
Relative Strength Index (RSI) 57.87 62.75
Support Level $169.65 $11.73
Resistance Level $185.70 $16.75
Average True Range (ATR) 5.45 1.14
MACD 0.06 0.24
Stochastic Oscillator 73.40 93.01

Price Performance

Historical Comparison
AGM
GENB

About AGM Federal Agricultural Mortgage Corporation

Federal Agricultural Mortgage Corp provides agricultural real estate and rural housing mortgage loans in the secondary market in the U.S. Its operations consist of seven reportable segments: Farm & Ranch, which generates maximum revenue, Corporate AgFinance, Power & Utilities, Broadband Infrastructure, Renewable Energy, Funding, and Investments. The company purchases eligible mortgage loans secured by first liens on agricultural real estate and rural housing under the Farm & Ranch line of business. Its subsidiary purchases portions of certain agricultural, rural development, business and industry, and community facilities loans guaranteed by the USDA. Geographically, the company's operations are spread across different regions in the United States.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: